Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib Ointment in Chronic Plaque Psoriasis
NCT01831466Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of INN-04-01 in plaque psoriasis, sponsored by Pfizer. Started May 2013; status: completed.
02
Drugs
INN-04-01
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01831466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01831466.